Skip to main content

Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.

Publication ,  Journal Article
Stine, JG; Long, MT; Corey, KE; Sallis, RE; Allen, AM; Armstrong, MJ; Conroy, DE; Cuthbertson, DJ; Duarte-Rojo, A; Hallsworth, K; Hickman, IJ ...
Published in: Med Sci Sports Exerc
September 1, 2023

Although physical activity (PA) is crucial in the prevention and clinical management of nonalcoholic fatty liver disease, most individuals with this chronic disease are inactive and do not achieve recommended amounts of PA. There is a robust and consistent body of evidence highlighting the benefit of participating in regular PA, including a reduction in liver fat and improvement in body composition, cardiorespiratory fitness, vascular biology, and health-related quality of life. Importantly, the benefits of regular PA can be seen without clinically significant weight loss. At least 150 min of moderate or 75 min of vigorous intensity PA are recommended weekly for all patients with nonalcoholic fatty liver disease, including those with compensated cirrhosis. If a formal exercise training program is prescribed, aerobic exercise with the addition of resistance training is preferred. In this roundtable document, the benefits of PA are discussed, along with recommendations for 1) PA assessment and screening; 2) how best to advise, counsel, and prescribe regular PA; and 3) when to refer to an exercise specialist.

Duke Scholars

Published In

Med Sci Sports Exerc

DOI

EISSN

1530-0315

Publication Date

September 1, 2023

Volume

55

Issue

9

Start / End Page

1717 / 1726

Location

United States

Related Subject Headings

  • United States
  • Sports Medicine
  • Sports
  • Sport Sciences
  • Quality of Life
  • Non-alcoholic Fatty Liver Disease
  • Humans
  • Exercise
  • 4207 Sports science and exercise
  • 3208 Medical physiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stine, J. G., Long, M. T., Corey, K. E., Sallis, R. E., Allen, A. M., Armstrong, M. J., … Schmitz, K. H. (2023). Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc, 55(9), 1717–1726. https://doi.org/10.1249/MSS.0000000000003199
Stine, Jonathan G., Michelle T. Long, Kathleen E. Corey, Robert E. Sallis, Alina M. Allen, Matthew J. Armstrong, David E. Conroy, et al. “Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.Med Sci Sports Exerc 55, no. 9 (September 1, 2023): 1717–26. https://doi.org/10.1249/MSS.0000000000003199.
Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, et al. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023 Sep 1;55(9):1717–26.
Stine, Jonathan G., et al. “Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.Med Sci Sports Exerc, vol. 55, no. 9, Sept. 2023, pp. 1717–26. Pubmed, doi:10.1249/MSS.0000000000003199.
Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TL, Vilar-Gomez E, Wong VW-S, Schmitz KH. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023 Sep 1;55(9):1717–1726.

Published In

Med Sci Sports Exerc

DOI

EISSN

1530-0315

Publication Date

September 1, 2023

Volume

55

Issue

9

Start / End Page

1717 / 1726

Location

United States

Related Subject Headings

  • United States
  • Sports Medicine
  • Sports
  • Sport Sciences
  • Quality of Life
  • Non-alcoholic Fatty Liver Disease
  • Humans
  • Exercise
  • 4207 Sports science and exercise
  • 3208 Medical physiology